Cargando…
High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy
Neoadjuvant chemotherapy (NAC) is a widely-used treatment for breast cancer, as it may render unresectable breast tumors to become resectable. In addition, NAC provides the unique opportunity to assess response to treatments within months rather than years of follow-up. However, predictive markers o...
Autores principales: | Rau, Kun-Ming, Su, Yu-Li, Li, Shan-Hsuan, Hsieh, Meng-Che, Wu, Shis-Chung, Chou, Fong-Fu, Chiu, Tai-Jan, Chen, Yen-Hao, Liu, Chien-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865844/ https://www.ncbi.nlm.nih.gov/pubmed/28944897 http://dx.doi.org/10.3892/mmr.2017.7555 |
Ejemplares similares
-
The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
por: Beresford, M J, et al.
Publicado: (2006) -
S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
por: Hsieh, Meng-Che, et al.
Publicado: (2020) -
Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2014) -
Endoglin: Beyond the Endothelium
por: Schoonderwoerd, Mark J. A., et al.
Publicado: (2020) -
MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012)